Drs Roy Herbst and David Rimm review how biomarker testing has transformed the way patients with lung cancer are treated, and how both medical oncologists and pathologists contribute to these changes.
Video Library —July 18, 2018
Categories:
Interview with the InnovatorsEnsign Professor of Medicine
Chief of Medical Oncology
Director, Thoracic Oncology Research Program Associate Director for Translational
Research Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, CT
Chief of Medical Oncology
Director, Thoracic Oncology Research Program Associate Director for Translational
Research Yale Comprehensive Cancer Center
Yale School of Medicine
New Haven, CT
Professor of Pathology and Medicine (Oncology)
Yale University School of Medicine
New Haven, CT
Yale University School of Medicine
New Haven, CT
Last modified: August 10, 2023